Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Message me
Patients With Renal Impairment Dapagliflozin At steady-state (20 mg once daily dapagliflozin for 7 days), adult patients with type 2 diabetes mellitus with mild, moderate, or severe renal impairment (as determined by eGFR) had geometric mean systemic exposures of dapagliflozin that were 45%, 100% and 200% higher, respectively, as compared to patients with type 2 diabetes mellitus with normal renal function
Is a Certificate of Analysis provided
The finished compounded product is not reviewed or approved by the FDA
US$ 26.72
US$ 28.27
US$ 28.94
US$ 22.86
US$ 24.04
US$ 23.60
